Ethyl Pyruvate Administration Suppresses Growth and Invasion of Gallbladder Cancer Cells via Downregulation of Hmgb1-Rage Axis

Abstract

High mobility group box B1 (HMGB1)-receptor for advanced glycation endproducts (RAGE) axis has been previously known to be involved in carcinogenesis and development of multiple malignancies. Some studies have confirmed that Ethyl pyruvate (EP), a potent inhibitor of HMGB1, exerts the therapeutic effects on metastatic live tumor from gastric cancer. However, the effects and possible molecular mechanisms of EP on gallbladder cancer (GBC) need to be further explored. In the present study, human GBC cell lines (GBC-SD and SGC-996) were treated with different concentrations of EP. Then, the expression levels of HMGB1, RAGE and some transcription factors were identified by Real-time PCR and Western blot assays. Cell proliferative activities indicated by MTT assay, invasive potential by Transwell assay and cell apoptosis and cycle distribution were performed for functional analysis of GBC cell lines in vitro. As a result, EP decreased the expression of HMGB11, RAGE, PCNA and matrix metallopeptidase-9 (MMP-9), while it increased the expression of p53. Moreover, EP administration decreased GBC cell proliferation, inhibited the invasive potential, and induced apoptosis and cycle arrest in S phase in GBC cells. In conclusion, EP administration inhibits growth and invasion of gallbladder cancer cells possibly via down-regulation of the HMGB1-RAGE axis, suggesting that EP may play a critical role in the treatment of cancer in conjunction with other therapeutic agents.

Keywords

ethyl pyruvate HMGB1 RAGE growth invasion gallbladder cancer

References

Lotze

DeMarco

. Dealing with death: HMGB1 as a novel target for cancer therapy. Curr Opin Investig Drugs 2003; 4:1405–9.

Dumitriu

Baruah

Valentinis

. Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products. J Immunol 2005; 174:7506–15.

Sasahira

Akama

Fujii

Kuniyasu

. Expression of receptor for advanced glycation end products and HMGB1/amphoterin in colorectal adenomas. Virchows Arch 2005; 446:411–5.

Han

Kim

Mook-Jung

. RAGE: The beneficial and deleterious effects by diverse mechanisms of actions. Mol Cells 2011; 31:91–7.

Kuniyasu

Oue

Wakikawa

. Expression of receptors for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer. J Pathol 2002; 196:163–70.

Allmen

Koch

Fritz

Legler

. V domain of RAGE interacts with AGEs on prostate carcinoma cells. Prostate 2008; 68:748–58.

Sasahira

Kirita

Bhawal

Ikeda

Nagasawa

Yamamoto

Kuniyasu

. The expression of receptor for advanced glycation end products is associated with angiogenesis in human oral squamous cell carcinoma. Virchows Arch 2007; 450:287–95.

Lin

Zhong

Sun

Ding

. Receptor for advanced glycation end products (RAGE) partially mediates HMGB1-ERKs activation in clear cell renal cell carcinoma. J Cancer Res Clin Oncol 2012; 138:11–22.

Alexiou

Chatzopoulou

Pegklidou

Demopoulos

. RAGE: A multi-ligand receptor unveiling novel insights in health and disease. Curr Med Chem 2010; 17:2232–52.

10.

Das

. Pyruvate is an endogenous anti-inflammatory and anti-oxidant molecule. Med Sci Monit 2006; 12:RA79–84.

11.

Lim

Choi

Kim

Duong

Jeong

Kang

Han

. Ethyl pyruvate induces necrosis-to-apoptosis switch and inhibits high mobility group box protein 1 release in A549 lung adenocarcinoma cells. Int J Mol Med 2007; 20:187–92.

12.

Hirata

Takada

Suzuki

Kuroda

, Expression of receptor for advanced glycation end products (RAGE) in human biliary cancer cells. Hepatogastroenterology 2003; 50:1205–7.

13.

Tan

Zhang

Ding

Liu

, NLK is a key regulator of proliferation and migration in gallbladder carcinoma cells. Mol Cell Biochem 2012; 369:27–33.

14.

Wang

Peng

Liu

. Identification of metastasis-associated proteins involved in gallbladder carcinoma metastasis by proteomic analysis and functional exploration of chloride intracellular channel 1. Cancer Letters 2009; 281:71–81.

15.

Quan

Dong

. Reactive oxygen species-mediated endoplasmic reticulum stress and mitochondrial dysfunction contribute to cirsimaritin-induced apoptosis in human gallbladder carcinoma GBC-SD cells. Cancer Lett 2010; 295:252–9.

16.

Dong

Zhang

. Wogonin, an active ingredient of Chinese herb medicine Scutellaria baicalensis, inhibits the mobility and invasion of human gallbladder carcinoma GBC-SD cells by inducing the expression of maspin. J Ethnopharmacol 2011; 137:1373–80.

17.

Zhang

Wang

. Effects of matrine on proliferation and apoptosis in gallbladder carcinoma cells (GBC-SD). Phytother Res 2012; 26:932–7.

18.

Todorova

Pasheva

. High mobility group B1 protein interacts with its receptor RAGE in tumor cells but not in normal tissues. Oncol Lett 2012; 3:214–8.

19.

Sparatore

Pedrazzi

Passalacqua

Gaggero

Patrone

Pontremoli

Melloni

. Stimulation of erythroleukaemia cell differentiation by extracellular high-mobility group-box protein 1 is independent of the receptor for advanced glycation end-products. Biochem J 2002; 363:529–35.

20.

Kuniyasu

Yano

Sasaki

Sasahira

Sone

Ohmori

. Colon cancer cell-derived high mobility group 1/amphoterin induces growth inhibition and apoptosis in macrophages. Am J Pathol 2005; 166:751–60.

21.

Riuzzi

Sorci

Donato

. The amphoterin (HMGB1)/receptor for advanced glycation end products (RAGE) pair modulates myoblast proliferation, apoptosis, adhesiveness, migration, and invasiveness. Functional inactivation of RAGE in L6 myoblasts results in tumor formation in vivo. J Biol Chem 2006; 281:8242–53.

22.

Liang

Chavez

Schapiro

. Ethyl pyruvate administration inhibits hepatic tumor growth. J Leukoc Biol 2009; 86:599–607.

23.

Muller

DuHadaway

Jailer

Curtis

Metz

Prendergast

. Immunotherapeutic suppression of indoleamine 2,3-dioxygenase and tumor growth with ethyl pyruvate. Cancer Res 2010; 70:1845–53.

24.

Zhang

Zhu

J-S

Zhou

. Therapeutic effects of ethyl pyruvate on tumor growth and metastasis in a severe combined immunodeficiency mouse orthotopic implantation model. Eur J Inflamm 2012; 10:25–32.

25.

Hanada

Itoh

Fujii

Tsuchida

Ishimaru

Hirata

Kajiyama

. Expression of the proliferative cell nuclear antigen (PCNA) in adenocarcinoma of the gallbladder, and its relationship to prognosis. Scand J Clin Lab Invest 1995; 55:377–82.

26.

Karadag

Kirimlioglu

Isik

Yilmaz

Kirimlioglu

. Expression of matrix metalloproteinases in gallbladder carcinoma and their significance in carcinogenesis. Appl Immunohistochem Mol Morphol 2008; 16:148–52.

27.

Vaseva

Moll

. The mitochondrial p53 pathway. Biochim Biophys Acta 2009; 1787:414–20.

28.

Kang

Tang

Schapiro

. The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival. Cell Death Differ 2010; 17:666–76.

29.

Takada

Hirata

Ajiki

Suzuki

Kuroda

. Expression of receptor for advanced glycation end products (RAGE) and MMP-9 in human pancreatic cancer cells. Hepatogastroenterology 2004; 51:928–30.

30.

Zhang

Zhu

Zhou

Chen

. Inhibitory effects of ethyl pyruvate administration on human gastric cancer growth via regulation of the HMGB1-RAGE and Akt pathways in vitro and in vivo. Oncol Rep 2012; 27:1511–9.